Cargando…

Editorial: Decoding checkpoint inhibitor-induced immune-related adverse events, volume II

Detalles Bibliográficos
Autores principales:	Burnett, Deborah L., Barnet, Megan B., Moxon, Ania, Tsang, Venessa, Samaras, Katherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622750/ https://www.ncbi.nlm.nih.gov/pubmed/37929033 http://dx.doi.org/10.3389/fendo.2023.1317220

Ejemplares similares

Editorial: Decoding checkpoint inhibitor-induced endocrinopathies
por: Burnett, Deborah L., et al.
Publicado: (2022)

Insights Into the Host Contribution of Endocrine Associated Immune-Related Adverse Events to Immune Checkpoint Inhibition Therapy
por: Chye, Adrian, et al.
Publicado: (2022)

Editorial: With obesity becoming the new normal, what should we do? ‐Volume II
por: Tziomalos, Konstantinos, et al.
Publicado: (2022)

Immune Related Adverse Events of the Thyroid – A Narrative Review
por: Muir, Christopher A., et al.
Publicado: (2022)

Thyroid-related adverse events induced by immune checkpoint inhibitors
por: Chera, Alexandra, et al.
Publicado: (2022)

Editorial: Women in endocrinology 2021
por: Perks, Claire M., et al.
Publicado: (2022)

Editorial: Cancer and bone metastasis, volume II
por: Mandal, Chandi C., et al.
Publicado: (2022)

Editorial: COVID-19 and diabetes, volume II
por: Ali, Hamad, et al.
Publicado: (2023)

Editorial: Neuropeptide GPCRs in neuroendocrinology, Volume II
por: Vaudry, Hubert, et al.
Publicado: (2023)

Editorial: Advances in the research of diabetic nephropathy, volume II
por: Iizuka, Katsumi, et al.
Publicado: (2023)

Editorial: Translational research in thyroid cancer, Volume II
por: Cheng, Sheue-yann, et al.
Publicado: (2023)

Editorial: Advances in the research of diabetic retinopathy, volume II
por: Nawaz, Mohd Imtiaz
Publicado: (2023)

Editorial: (Osteo)sarcopenia & sarcopenic obesity, volume II
por: Kostoglou-Athanassiou, Ifigenia, et al.
Publicado: (2023)

Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside
por: Wu, Linda, et al.
Publicado: (2021)

Editorial: Follicle-stimulating hormone: Fertility and beyond-volume II
por: Simoni, Manuela, et al.
Publicado: (2022)

Editorial: Diagnosis, prevention and treatment in diabetic nephropathy, volume II
por: Cecchini, Andrea Leonardo, et al.
Publicado: (2023)

Editorial: Cardiovascular diseases related to diabetes and obesity – volume II
por: Young, Jamie L., et al.
Publicado: (2022)

Editorial: Debates in clinical management in pediatric endocrinology, volume II
por: De Filippo, Gianpaolo, et al.
Publicado: (2023)

Editorial: Polycystic ovary syndrome: mechanism and management—volume II
por: Wang, Yishu, et al.
Publicado: (2023)

Editorial: Endocrine and metabolic consequences of childhood obesity, volume II
por: Mazur, Artur, et al.
Publicado: (2023)

Editorial: Assessment of osteoporotic fractures and risk prediction, volume II
por: Xie, Dandan, et al.
Publicado: (2023)

Phenotypic Differences in Thyroid Immune Related Adverse Events Following Treatment With Immune Checkpoint Inhibitors
por: Muir, Christopher Alan, et al.
Publicado: (2021)

Editorial: Metabolically healthy and unhealthy obese children and adolescents, volume II
por: Xi, Bo, et al.
Publicado: (2022)

Editorial: Male idiopathic infertility: Novel possible targets, volume II
por: Cannarella, Rossella, et al.
Publicado: (2023)

Editorial: Sex determination and developmental mechanism of crustaceans and shellfish, volume II
por: Farhadi, Ardavan
Publicado: (2023)

Editorial: Obesogens in the XXI century: emerging health challenges volume II
por: Sousa, Ana C. A., et al.
Publicado: (2023)

Editorial: Disruptors on male reproduction—emerging risk factors, volume II
por: Chen, Qing, et al.
Publicado: (2023)

Editorial: Pharmacological and non-pharmacological therapy for obesity and diabetes - volume II
por: Oliveira, Alexandre Gabarra, et al.
Publicado: (2023)

Editorial: Molecular and cytogenetic research advances in human reproduction - volume II
por: Chu, Xiufeng, et al.
Publicado: (2023)

Editorial: Association of novel anthropometric indexes with metabolic syndrome and beyond, volume II
por: Mohammadian Khonsari, Nami, et al.
Publicado: (2023)

Editorial: The impact of adipose tissue dysfunction on cardiovascular and renal disease, Volume II
por: Sun, Xiaodong, et al.
Publicado: (2023)

Editorial: Obesity, hyperglycemia, and pregnancy: from pathophysiology to clinical practice - volume II
por: Succurro, Elena, et al.
Publicado: (2023)

Editorial: Subclinical thyroid disease: present knowledge and future direction, volume II
por: Garduno Garcia, Jose De Jesus, et al.
Publicado: (2023)

Editorial: Systemic regulation of organ homeostasis and implications of hormones and immunity, Volume II
por: Pidugu, Vijaya Kumar, et al.
Publicado: (2023)

Editorial: Thyroid hormone and metabolites: central versus peripheral effects, volume II
por: de Lange, Pieter, et al.
Publicado: (2023)

Editorial: With Obesity Becoming the New Normal, What Should We Do?
por: Samaras, Katherine, et al.
Publicado: (2019)

Editorial: Complexity of tumor microenvironment: A major culprit in cancer development, volume II
por: Bukhari, Ihtisham, et al.
Publicado: (2023)

Editorial: Immune-related adverse events for patients with lung cancer-volume II
por: Wang, Yusha, et al.
Publicado: (2023)

Editorial: Keeping the Body in Mind: Scientific Effort in Advocating the Best Outcomes for People Living With Severe Mental Illness
por: Samaras, Katherine, et al.
Publicado: (2022)

Editorial: Advances of endocrine and metabolic cardiovascular outcomes: From basic to clinical science, volume II
por: Cheng, Wenzhuo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_abkenteoph1mqgikgqss6b9e87